17 related news articles for
-
Bacteria and stomach cancer: breaking the link
H. pylori – short for Helicobacter pylori – colonises the stomach and is known to be linked to the development of stomach cancer. It is estimated that over half of the world’s population is infected with H. pylori, making it one of the most common bacterial infections.… Read more
-
New anti-inflammatory: one medicine to rule them all
A new class of anti-inflammatory drug is opening a world of possibilities for treating everything from neurological diseases to cancers.… Read more
-
Hudson Institute’s 2023 Emerging Leaders
Six of the best early career researchers have been chosen to take part in the Hudson Institute 2023 Emerging Leaders Program. … Read more
-
Lymphoma treatment targets multiple diseases
The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success – identifying a potential molecular target to treat other related forms of lymphoma as well.… Read more
-
Two new proteins identified as keys to intestinal health
Two new candidates have been identified as crucial factors in maintaining good intestinal health.… Read more
-
US Defense Dept backs Aussie upper gastrointestinal cancer research
If an army marches on its stomach, as the old saying goes, then the US Department of Defense (DoD) is investing wisely in Australian upper gastrointestinal cancer research.… Read more
-
Soy molecule may lead to new anti-inflammatory drug
A naturally occurring molecule found in soy products could hold the clue to a new class of potent anti-inflammatory drugs, targeting diseases ranging from heart conditions to COVID-19.… Read more
-
Combatting a killer – understanding what causes small cell lung cancer
A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.… Read more
-
2021 NHMRC Ideas Grants success
Hudson Institute has again been recognised in the awarding of NHMRC Ideas Grants. These grants support innovative and creative research and build on Australia’s strong skills and international reputation in advanced health and medical research.… Read more
-
ARC Discovery Projects success
Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.… Read more
-
The Ron Evans AM Fellowship
Congratulations to Dr Marius Dannappel and Dr Madara Ratnadiwakara who have been awarded The Ron Evans AM Fellowship to progress treatments for bowel cancer.… Read more
-
Strengthening international collaborations with the University of Toronto
A two-day workshop is being held to promote collaborative research opportunities between cancer and inflammation researchers at Hudson Institute and the Department of Immunology at the University of Toronto.… Read more
-
NHMRC Fellowship success
Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.… Read more
-
2018 Hudson Institute Travel and Equity Awards
Congratulations to the 2018 Hudson Institute Travel Awards recipients, who will attend international conferences and visiting laboratories to build invaluable knowledge in their area of research. The Awards (supported by donations from the Grisha Sklovsky Memorial Fund and Philip Wind Travel Fund) support six Hudson Institute Postdoctoral Fellows and PhD students to gain experience relevant… Read more
-
Fielding Foundation Fellowship awarded to two emerging immunology research leaders
The Fielding Foundation Fellowship 2017 has been jointly awarded to two outstanding immunology researchers at Hudson Institute, Dr Niamh Mangan, from the Centre for Innate Immunity and Infectious Diseases, and Associate Professor Marcel Nold, from The Ritchie Centre.… Read more
-
Scientists discover new pathways controlling deadly inflammation
Inflammation is an important response to infection or injury, but needs to be carefully controlled as too much inflammation can cause conditions such as cancer, diabetes, heart disease and Alzheimer’s disease.… Read more
-
ARC Future Fellow to target early cancer detection
The Australian Research Council has awarded leading scientist and biological engineer, Dr Michael Gantier, a 2014 Future Fellowship for his outstanding research at the MIMR-PHI Institute.… Read more